Drug pricing, patent losses and deals: Here's what pharma execs see ahead in the industry - CNBC
- Drug pricing, patent losses and deals: Here's what pharma execs see ahead in the industry CNBC
- 2025 ended on high note with a buoyant Q4 for M&A, PIPEs and follow-ons Endpoints News
- 2026 Biopharma Outlook Infographic evaluate.com
- Come Together: Pharma M&A set to accelerate in 2026 ING THINK economic and financial analysis | ING THINK
- Global financial services M&A rises in 2025, powered by ‘megadeals’ Investment Executive